Klarna, nearing IPO, plucks lucrative Walmart fintech partnership from rival Affirm

Key Points

Swedish fintech firm Klarna will be the exclusive provider of buy now, pay later loans for Walmart, taking a coveted partnership away from rival Affirm, CNBC has learned.
Klarna, which disclosed its intention to go public in the U.S., will provide loans to Walmart customers in stores and online through the retailer’s majority-owned fintech startup OnePay, according to people with knowledge of the situation.
OnePay, which updated its brand name this month, will handle the user experience via its app, while Klarna will make underwriting decisions for loans ranging from 3 months to 36 months in length.

Source

Finance

JPMorgan Chase-led bank group reins in credit line to troubled KKR private credit fund as losses mount

May 11, 2026

Key Points JPMorgan-led lenders cut FS KKR Capital’s credit facility by roughly $648 million, or 14%, while raising borrowing costs. FS KKR reported deepening losses and announced a $300 million support package from KKR for the troubled BDC days after the credit-line amendment. The fund, known by its ticker FSK, reported roughly $560 million in […]

Finance

Michael Burry is not a believer: ‘For any stocks going parabolic reduce positions almost entirely’

May 11, 2026

Key Points Michael Burry said investors should “reject greed” as enthusiasm around artificial intelligence and momentum-driven trades pushes valuations sharply higher. “An easier way for most is to simply reduce exposure to stocks, to tech stocks in particular. For any stocks going parabolic reduce positions almost entirely,” Burry wrote. Source

Finance

Stocks making the biggest moves premarket: Moderna, Lumentum, Intel, monday.com & more

May 11, 2026

Check out the companies making the biggest moves premarket: Moderna — The biotechnology company was up almost 9% after a U.S. citizen tested positive for the hantavirus. Another American had symptoms for the virus, but had yet to test positive, the Associated Press reported . Moderna last week announced that it was in the early-stage […]